Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $3.6500 (0.55%) ($3.6500 - $3.6500) on Wed. Apr. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 35 | Latest Price | $3.6500(0.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2.1% a day on average for past five trading days. | Weekly Trend | AUTL declines -6.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) PAVE(84%) XBI(83%) IBB(78%) XLK(71%) INDA(69%) | Factors Impacting AUTL price | AUTL will decline at least -1.805% in a week (0% probabilities). TIP(-89%) UNG(-67%) SHY(-36%) XLU(-33%) USO(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.62(-336.16%) | Resistance Level | $4.19 | 5 Day Moving Average | $3.82(-4.45%) | 10 Day Moving Average | $4.08(-10.54%) | 20 Day Moving Average | $4.19(-12.89%) | To recent high | -22% | To recent low | 4.1% | Market Cap | $191m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |